HIV-1 plasma variants encoding truncated reverse trancriptase (RT) in a patient with high RT-specific CD8+ memory T-cell response

Current HIV Research

Volumn 7, Issue 3, 2009, Pages 302-310

  Paolucci, Stefania ^a   Foli, Andrea ^a   Gulminetti, Roberta ^a   Calarota, Sandra A ^a   Maserati, Renata ^a   Baldanti, Fausto ^a   Gerna, Giuseppe ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

APOBEC; CD8+ T cell response; Cultured ELISPOT; Replication deficient HIV 1; RT stop codons

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; ATAZANAVIR; DIDANOSINE; GAG PROTEIN; INDINAVIR; LAMIVUDINE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; POL PROTEIN; PROTEIN P17; RITONAVIR; RNA DIRECTED DNA POLYMERASE; STAVUDINE; VIRUS DNA; VIRUS RNA; ZIDOVUDINE; REVERSE TRANSCRIPTASE, HUMAN IMMUNODEFICIENCY VIRUS 1;

ADULT; ANTIGEN SPECIFICITY; CASE REPORT; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CONSENSUS SEQUENCE; DNA SEQUENCE; ENZYME LINKED IMMUNOSPOT ASSAY; GENE EXPRESSION; GENE POOL; GENETIC CODE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; MALE; MEMORY T LYMPHOCYTE; NONHUMAN; PATIENT COMPLIANCE; PERIPHERAL BLOOD MONONUCLEAR CELL; REVIEW; RNA SEQUENCE; STOP CODON; STRUCTURAL GENE; VIRUS MUTATION; VIRUS REPLICATION; AMINO ACID SEQUENCE; ARTICLE; CELL CULTURE; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; VIROLOGY;

ADULT; AMINO ACID SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CODON, NONSENSE; HIV INFECTIONS; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; MALE; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA;

EID: 67649126332     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016209788347930     Document Type: Review

References (33)

1. Preston BD, Poiesz BJ, Loeb LA. Fidelity of HIV-1 reverse transcriptase. Science 1988; 242: 1168-71.
2. Steinhauer DA, Domingo E, Holland JJ. Lack of evidence for proofreading mechanisms associated with an RNA virus polymerase. Gene 1992; 122: 281-8.
3. Makinson A, Masquelier B, Taieb A, et al. Presence of numerous stop codons in HIV-1 reverse transcriptase proviral DNA sequences from patients with virological response to HAART. AIDS 2006; 20: 1327-36.
4. Wang B, Mikhail M, Dyer WB, Zaunders JJ, Kelleher AD, Saksena NK. First demonstration of lack of viral sequence evolution in a nonprogressor, defining replication-incompetent HIV-1 infection. Virology 2003; 312: 135-50.
5. Wherry EJ, Teichgräber V, Becker TC, et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 2003; 4: 225-34.
6. Wherry EJ, Ahmed R. Memory CD8 T-cell differentiation during viral infection. J Virol 2004; 78: 5535-45.
7. Paolucci S, Baldanti F, Maserati R, et al. Quantification of the impact of HIV-1 reverse transcriptase and protease mutations on the efficacy of rescue HAART. Antiviral Res 2000; 45: 101-14.
8. Paolucci S, Baldanti F, Zavattoni M, et al. Comparison of levels of HIV-1 resistance to protease inhibitors by recombinant versus conventional virus phenotypic assay and two genotypic interpretation procedures in treatment-naive and HAART-experienced HIV-infected patients. J Antimicrob Chemother 2003; 51: 135-9.
9. Coplan PM, Gupta SB, Dubey SA, et al. Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents. J Infect Dis 2005; 191(9): 1427-34.
10. Inwoley A, Recordon-Pinson P, Dupuis M, et al. Cross-clade conservation of HIV type 1 Nef immunodominant regions recognized by CD8+ T cells of HIV type 1 CRF02_AG-infected Ivorian (West Africa). AIDS Res Hum Retroviruses 2005; 21: 620-8.
11. Calarota SA, Foli A, Maserati R, et al. HIV-1-specific T-cell precursors with high proliferative capacity correlate with low viremia and high CD4 counts in untreated individuals. J Immunol 2008; 180: 5907-15.
12. Baldanti F, Paolucci S, Ravasi G, et al. Changes in circulation of B and non-B HIV strains: Spotlight on a reference centre for infectious diseases in Northern Italy. J Med Virol 2008; 80: 947-52.
13. + T cells in vivo. J Virol 2005; 79: 1975-80.
14. Iwabu Y, Goto T, Tsuji S, et al. Superinfection of human immunodeficiency virus type 1 (HIV-1) to cell clone persistently infected with defective virus induces production of highly cytopathogenic HIV-1. Microbes Infect 2006; 8: 1773-82.
15. Cara A, Guarnaccia F, Reitz MS, Gallo RC, Lori F. Self-limiting, cell type-dependent replication of an integrase-defective human immunodeficiency virus type 1 in human primary macrophages but not T lymphocytes. Virology 1995; 208: 242-8.
16. gag-pol mutants with truncations downstream of the protease domain. Virology 2004; 329: 180-8.
17. Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MB. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994; 68: 6103-10.
18. Koup RA, Safrit JT, Cao Y, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994; 68: 4650-5.
19. Klein MR, van Baalen CA, Holwerda AM, et al. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J Exp Med 1995; 181: 1365-72.
20. Ogg GS, Jin X, Bonhoeffer S, et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998, 279: 2103-6.
21. Addo MM, Yu XG, Rathod A, et al. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol 2003; 77: 2081-92.
22. Cao J, McNevin J, Holte S, Fink L, Corey L, McElrath MJ. Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection. J Virol 2003; 77: 6867-78.
23. Frahm N, Korber BT, Adams CM, et al. Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities. J Virol 2004; 78: 2187-200.
24. Peretz Y, Alter G, Boisvert MP, Hatzakis G, Tsoukas CM, Bernard NF. Human immunodeficiency virus (HIV)-specific gamma interferon secretion directed against all expressed HIV genes: relationship to rate of CD4 decline. J Virol 2005; 79: 4908-17.
25. Martinez V, Costagliola D, Bonduelle O, et al. Combination of HIV-1-specific CD4 Th1 cell responses and IgG2 antibodies is the best predictor for persistence of long-term nonprogression. J Infect Dis 2005; 191: 2053-63.
26. Reece WH, Pinder M, Gothard PK, et al. A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease. Nat Med 2004; 10: 406-10.
27. Keating SM, Bejon P, Berthoud T, et al. Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria. J Immunol 2005; 175: 5675-80.
28. Webster DP, Dunachie S, Vuola JM, et al. Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara. PNAS 2005; 102: 4836-41.
29. Yang SH, Lee CG, Park SH, et al. Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study. Gene Ther 2006; 13: 1110-7.
30. Goonetilleke N, Moore S, Dally L, et al. Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag coupled to CD8+ T-cell epitopes. J Virol 2006; 80: 4717-28.
31. Kalams SA, Goulder PJ, Shea AK, et al. Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy. J Virol 1999; 73: 6721-8.
32. Sester U, Sester M, Köhler H, et al. Maintenance of HIV-specific central and effector memory CD4 and CD8 T cells requires antigen persistence. AIDS Res Hum Retroviruses 2007; 23: 549-53.
33. Haigh J. The accumulation of deleterious genes in a population - Muller's Ratchet. Theor Popul Biol 1978; 14: 251-67.